---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-094976"
form_type: "8-K"
ticker: "EMMA"
cik: "0000822370"
company_name: "Emmaus Life Sciences, Inc."
filed_at: "2024-11-06T23:59:59+00:00"
generated_at: "2026-05-30T04:57:50.388133+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Director Seah Lim resigns from Emmaus Life Sciences board for personal reasons

## Summary
- Dr. Seah Lim resigned as director on November 4, 2024, citing personal reasons.
- No replacement or successor director has been named at this time.
- The company expressed gratitude for Dr. Lim's service and support.

## SEC filing metadata
- accession: 0001213900-24-094976
- form_type: 8-K
- ticker: EMMA
- cik: 0000822370
- company_name: Emmaus Life Sciences, Inc.
- filed_at: 2024-11-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/822370/000121390024094976/0001213900-24-094976-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/822370/000121390024094976/ea0220098-8k_emmaus.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-094976
- JSON: https://secwatch.observer/filing/0001213900-24-094976.json
- Plain text: https://secwatch.observer/filing/0001213900-24-094976.txt

## Key facts
- Executive change
  Seah Lim resigned as director at Emmaus Life Sciences, Inc..
  - Action: resigned
  - Role: director
  source text: On November 4, 2024, Seah Lim, M.D., Ph.D., resigned as a director of Emmaus Life Sciences, Inc. (“we,” “us,” “our,” “Emmaus” or the “company”) for personal reasons and expressed his best wishes to the company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/822370/000121390024094976/0001213900-24-094976-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.